HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of a barrier teat dip containing .55% chlorhexidine for prevention of bovine mastitis.

Abstract
A natural exposure trial was conducted for 12 mo in a commercial herd of 125 lactating cows to compare the efficacy of an experimental barrier teat dip containing .55% chlorhexidine gluconate with the efficacy of a 1% iodophor for preventing new IMI and clinical mastitis. Teats of half of the cows were dipped in the experimental barrier product, and teats of the remaining half of the herd were dipped in the 1% iodophor product. Quarters dipped with the experimental barrier product had fewer new IMI caused by Escherichia coli, coagulase-negative staphylococci, or Gram-positive bacilli than did quarters dipped in the 1% iodophor. Incidence of new IMI caused by Serratia spp. and Pseudomonas spp. was greater for quarters dipped in the experimental barrier product than for quarters dipped in the 1% iodophor. Efficacy of the two teat dips against new IMI caused by Staphylococcus aureus, environmental streptococci, and Klebsiella spp. did not differ. Incidence of bacteriologically negative clinical cases of mastitis was greater in quarters dipped in the 1% iodophor than in quarters dipped in the experimental barrier product. Incidence of clinical mastitis cases caused by Staph. aureus, environmental streptococci, E. coli, Klebsiella spp., Serratia spp., and Pseudomonas spp. did not differ between treatment groups.
AuthorsJ S Hogan, K L Smith, D A Todhunter, P S Schoenberger
JournalJournal of dairy science (J Dairy Sci) Vol. 78 Issue 11 Pg. 2502-6 (Nov 1995) ISSN: 0022-0302 [Print] United States
PMID8747340 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Anti-Infective Agents, Local
  • Iodophors
  • chlorhexidine gluconate
  • Chlorhexidine
Topics
  • Animals
  • Anti-Infective Agents, Local (administration & dosage, therapeutic use)
  • Cattle
  • Chlorhexidine (administration & dosage, analogs & derivatives, therapeutic use)
  • Escherichia coli Infections (prevention & control, veterinary)
  • Female
  • Iodophors (administration & dosage, therapeutic use)
  • Lactation
  • Mammary Glands, Animal
  • Mastitis, Bovine (prevention & control)
  • Pseudomonas Infections (prevention & control, veterinary)
  • Serratia Infections (prevention & control, veterinary)
  • Staphylococcal Infections (prevention & control, veterinary)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: